Atlas Trials

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Clinical trial NCT00951535 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00951535
Sponsor
Cancer Trials Ireland
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2009-07-20
Primary completion
2026-05-01
Enrollment
251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.